Elevated nitric oxide production in patients with primary Sjogren's syndrome

Clinical Rheumatology

Volumn 19, Issue 5, 2000, Pages 360-364

  Wanchu, A ^a   Khullar, M ^a   Sud, A ^a   Bambery, P ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Citrulline; Nitric oxide; Nitrite; Primary Sjogren's syndrome

Indexed keywords

CITRULLINE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SJOEGREN SYNDROME; SPECTROPHOTOMETRY;

ADULT; AGED; BIOLOGICAL MARKERS; CITRULLINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; SPECTROPHOTOMETRY;

EID: 0033802912     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670070028     Document Type: Article

References (33)

1. NO at work
2. Inducible nitric oxide synthase in human diseases
3. Nitric oxide: Physiology, pathophysiology and pharmacology
4. Nitric oxide
5. Nitric oxide. An inflammatory mediator of glomerular mesangial cells
6. Nitric oxide in autoimmune disease: Cytotoxic or regulatory mediator?
7. The role of nitric oxide in inflammation and immunity
8. Nitric oxide and inflammatory joint disease
9. Cloned T lymphocytes synthesize a molecule with the biological characteristics of nitric oxide
10. L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells
11. Induction of nitric oxide synthase in rat immunocomplex glomerulonephritis
12. Nitric oxide production in cells derived from the human joint
13. Glomerular nitrite synthesis in situ immune-complex glomerulonephritis in the rat
14. N-Monomethyl arginine, an inhibitor of nitric oxide synthase suppresses the development of adjuvant arthritis in rats
15. Elevated urinary nitrite and citrulline levels in patients with rheumatoid arthritis
16. Increased concentration of nitrite and citrulline in serum samples suggest active disease in systemic lupus erythematosus
17. Role of nitric oxide in Sjogren's syndrome
18. Preliminary criteria for the classification of Sjogren's syndrome - Results of a prospective concerted action supported by the European Community
19. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids
20. Optimization of conditions for the calorimetric determination of citrulline, using diacetyl monoxime
21. Immunohistological analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies
22. Salivary gland lymphocytes in primary Sjiogren's syndrome lack lymphocyte subsets defined by Leu 7 and Leu 11 antigens
23. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides
24. Production of nitric oxide in the synovial membrane of rheumatoid arthritis and osteoarthritis
25. Cytokine transcription in salivary gland biopsies of Sjogren's syndrome
26. Molecular basis of 'suppressor' macrophages: Arginine metabolism via the nitric oxide synthase pathway
27. Nitric-oxide induced anti-mitogenic effects in high and low responder rat strains
28. A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carragreenin-induced oedema in mice
29. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-convening enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases
30. Nitric oxide induces apoptosis in mouse thymocytes
31. Lymphocyte apoptosis and apoptosis-associated gene expression in Sjogren's syndrome
32. Glucocorticoids inhibit expression of an inducible, but not constitutive nitric oxide synthase in the vascular endothelium
33. Nitric oxide production is increased in patients with inflammatory myositis